J&J COVID vaccine is effective against Omicron sub-variants

Safety and efficacy data of the Johnson & Johnson COVID-19 vaccine, recently published in the 'New England Journal of Medicine', found that a second dose of the jab offered up to 82% protection.

Related Keywords

South Africa ,California ,United States ,Culver City ,Patrickt Fallon ,Kevin Brandt ,Linda Gail Bekker ,Johnson ,Johnson Janssen ,Pfizer ,Culver City Fire Department ,New England Journal ,Professor Linda Gail Bekker ,Coronavirus ,Coronavirus Vaccine ,Covid 19 ,Covid 19 Vaccine ,J Ampj Covid 19 Vaccine ,Isonke Study Researchers ,Omicron Sub Variants ,Ocal ,